AMBA three-lens brief
Evidence-based stock research on AMBA. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Analyst mean target $89.36 — 32% above current (11 analysts). · Trading >3% below the 50-day MA — short-term weakness.
- Trading >3% below the 50-day MA — short-term weakness.
- Currently unprofitable on a trailing basis — no P/E multiple available.
- Analyst mean target $89.36 — 32% above current (11 analysts).
- 10-Q filing filed 2026-09-04.
- Reported earnings on 2026-09-03.
AMBA closed at $67.87 (-1.35%) as of 2026-09-11. Market cap: $3.00B. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $89.36 — 32% above current (11 analysts).. Concerns: trading >3% below the 50-day MA — short-term weakness.; currently unprofitable on a trailing basis — no P/E multiple available.. Last quarter: Revenue $108.13M, net income -$6.69M, free cash flow $32.83M.
Why three lenses on AMBA, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AMBAacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/AMBA" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AMBA brief"></iframe>